Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT06196957
Other study ID # REC/ 0346 samar
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date July 20, 2023
Est. completion date December 10, 2023

Study information

Verified date January 2024
Source Riphah International University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Effect of Senobi breathing exercise versus Buteyko breathing technique on functional performance among chronic obstructive pulmonary patient.


Description:

chronic obstructive pulmonary disease is a chronic inflammatory lung disease that cause obstructed airflow from the lungs. Symptoms include Breathing difficulty. cough, mucus production and wheezing. Its typically caused by long term exposure to irritating gasses or particulate matter, most often from cigarette smoker. Emphysema and chronic bronchitis are two most common condition that contribute to chronic obstructive pulmonary disease. Chronic obstructive pulmonary disease is progressive disease that gets over a time. Clinical trials will be Conducted in Gulab Devi chest hospital in Lahore. Through the convenient sampling Technique. Which will be allocated through the random sampling two groups are involved group A and group B. In group A check the effect of Senobi techniques (stretch the body) and in group B check the effect of Buteyko technique. (Inhale the through the nose while mouth is closed) by using 6 mint walk test, Borg scale and quality of life questionnaire. Apply the technique to check the effectiveness of dyspnea and quality of life of patient The Buteyko technique offers a complementary method of reliving respiratory symptoms based on the voluntary control of breathing as well as considering the effect of environmental and dietary trigger. Data will be collected by the questionnaire and analyzed by using statistical package for the social science SPSS software version 21. The Buteyko method made its way to Australia to Europe and the unite states in 1990, it become best for the asthma and chronic obstructive pulmonary disease patient. The Senobi stretch exercise of the respiratory muscle improve the chest expansion and also improve the chest wall mobility in chronic obstructive pulmonary disease patient. Senobi breathing exercise was found to be effective for depression and it regulate the sympathetic nerve activity.


Recruitment information / eligibility

Status Completed
Enrollment 32
Est. completion date December 10, 2023
Est. primary completion date December 1, 2023
Accepts healthy volunteers No
Gender All
Age group 40 Years to 80 Years
Eligibility Inclusion Criteria: - Age 40 -80 - COPD patient in stage 2 (GOLD criteria) - Dyspnea (FEV1< 70 %)(26) - Maximum expiratory pressure: 50% - Smoker Exclusion Criteria: - Patient with Tumor - Patient with Cardiac Arrhythmias Patient - Patient with cancer - insulin dependent diabetes - patient with thyroid disease

Study Design


Related Conditions & MeSH terms


Intervention

Combination Product:
pursed lip breathing
pursed lip breathing

Locations

Country Name City State
Pakistan Gulab devi chest hospital Lahore Punjab

Sponsors (1)

Lead Sponsor Collaborator
Riphah International University

Country where clinical trial is conducted

Pakistan, 

References & Publications (3)

Cortopassi F, Gurung P, Pinto-Plata V. Chronic Obstructive Pulmonary Disease in Elderly Patients. Clin Geriatr Med. 2017 Nov;33(4):539-552. doi: 10.1016/j.cger.2017.06.006. Epub 2017 Aug 23. — View Citation

Cowie RL, Conley DP, Underwood MF, Reader PG. A randomised controlled trial of the Buteyko technique as an adjunct to conventional management of asthma. Respir Med. 2008 May;102(5):726-32. doi: 10.1016/j.rmed.2007.12.012. Epub 2008 Jan 31. — View Citation

Opat AJ, Cohen MM, Bailey MJ, Abramson MJ. A clinical trial of the Buteyko Breathing Technique in asthma as taught by a video. J Asthma. 2000;37(7):557-64. doi: 10.3109/02770900009090810. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary CASA Q (cough and sputum ) The cough and sputum assessment questionnaire (CASA-Q) was used to measure the severity and impact of cough and sputum in patients with COPD and chronic bronchitis. CASA-Q scores of each domain demonstrated significant association with HRQoL impairment CASA-Q was strongly lower when chronic bronchitis was present, but multivariate analyses demonstrated that the association of HRQoL impairment was greater with the cough impact domain score than with the usual definition of chronic bronchitis. The CASA-Q targets cough and sputum by an original approach assessing both the symptoms and impacts in dailyactivities within the last 7 days. Each item is answered ranging from never to always or from not at all to a lot / extremely as applicable each type is answered using five categories. 4 weeks
Primary Dyspnea rating scale. This scale is used for the measurement of the dyspnea ( shortness of breath ).This scale is questionnaire that consist of 5 breathlessness grade ,and the number 5 have maximum dyspnea 4 weeks
See also
  Status Clinical Trial Phase
Not yet recruiting NCT05649891 - Checklists Resuscitation Emergency Department N/A
Completed NCT01604655 - ProspEctive First Evaluation in Chest Pain Trial N/A
Completed NCT01193998 - Impact of Validated Diagnostic Prediction Model of Acute Heart Failure in the Emergency Department N/A
Active, not recruiting NCT05139979 - Yogic Breathing and Guided Meditation for Long Covid Symptoms N/A
Completed NCT05586217 - Effects of Incentive Spirometry on Dyspnea and Chest Clearance in Asthmatic Patients During Seasonal Smog N/A
Completed NCT05812209 - Stellate Ganglion Block to Treat Long COVID 19 Case Series
Active, not recruiting NCT05479929 - Work of Breathing Assessment in Triage Scale
Active, not recruiting NCT00271128 - NT-proBNP for Evaluation of the Dyspneic Patient in the Emergency Room and the Medical Ward N/A
Recruiting NCT05667727 - The Effect of Nebulized Epinephrine in Asthma Exacerbation in Pediatric Age Group With the Standard Treatment Compared to Standard Treatment Using Improvement PRAM Score as a Primary Outcome Phase 4
Withdrawn NCT03696524 - Tunneled Pleural Catheters for Refractory Effusions Attributed to Congestive Heart Failure (TREAT-CHF) Trial N/A
Recruiting NCT04827563 - Dyspnea and Cardiotoxicity in Multiple Myeloma Patients Who Receive Carfilzomib
Withdrawn NCT05304494 - Sentinel - Triaging Acute Breathlessness Using Multi-Modal Biomarkers
Completed NCT01051960 - Exercise Induced Pulmonary Hypertension in Systemic Sclerosis and Treatment With Ambrisentan Phase 4
Completed NCT00537628 - Biomarkers in Acute Heart Failure N/A
Not yet recruiting NCT04332198 - Neurobiological and Immunological Mechanisms of Dyspnea in ALS (BIOPNEA) N/A
Recruiting NCT05992324 - A Validation Study to Evaluate the Performance of Caption Health Lung Guidance and Interpretation N/A
Completed NCT02055443 - Myocardial Ischemia Detection for Early Identification of Patients With Ischemic Chest Pain N/A
Completed NCT05708963 - The U.K. Embryologist Fatigue Study
Completed NCT04373499 - Virtual Teach-to-Goal Education vs. Brief Education for Children N/A
Recruiting NCT06201494 - Prospective Multicentre Study on Symptoms in First-onset Bronchial Asthma in Children and Adolescents